Abstract

Autism in Children

Author(s): Cave Stephanie

Issue: Jan/Feb 2001 - Compounding for Pediatric Patients

Page(s): 18-19

Download in electronic PDF format for $75
  • Autism in Children Page 1
  • Autism in Children Page 2

Abstract

Autism incorporates most of the characteristics of a metabolic disorder. In this discussion, the author focuses on biochemical markers, causes of autism and treatments.

Related Keywords

  • autism
  • autistic
  • autistic children

Related Categories

  • MENTAL HEALTH
  • PEDIATRICS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2001
Pg. 18-19
Autism in Children
Author(s): Cave Stephanie
Nov/Dec 2005
Pg. 413-420
Unlocking Autism: Is Compounding the Key?
Author(s): Vail Jane
Nov/Dec 2005
Pg. 487-488
PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Author(s): Neurander James A
Jul/Aug 2009
Pg. 296-299
Compounding Naltrexone for the Treatment of Autism
Author(s): Wynn Tom, Brunetti Sarah
Nov/Dec 2001
Pg. 436-437
Topical Secretin for the Treatment of Autism
Author(s): King Erin, Toney Steve
Sep/Oct 2006
Pg. 390
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Sep/Oct 2018
Pg. 358-366
Current Trends and Emerging Priorities in Compounded Preparations for Children
Author(s): Parrish Richard H II
Sep/Oct 2020
Pg. 367-369
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Author(s): Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
May/Jun 2016
Pg. 247-249
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Author(s): Nahata Milap C
May/Jun 2016
Pg. 257-261
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Sep/Oct 2017
Pg. 364-370
Child-safety Containers/Devices and Compounding
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 20-24
Sevelamer Suspension in Children with End-Stage Renal Disease
Author(s): McElhiney Linda F
Jan/Feb 2007
Pg. 5-8
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007
Pg. 27
Case Report: Treatment of Labial Adhesions in a Child
Author(s): Fields Shannon W
Jul/Aug 2008
Pg. 365-367
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2010
Pg. 10-13
Sleepless in America: Compounding with Melatonin
Author(s): Wynn Tom, Rawlings Kate
Jan/Feb 2013
Pg. 6-8
Pediatric Health Care: An Introduction
Author(s): Williams LaVonn A